Michael Horberg to HIV Integrase Inhibitors
This is a "connection" page, showing publications Michael Horberg has written about HIV Integrase Inhibitors.
Connection Strength
0.633
-
Incident diabetes after switching to integrase strand transfer inhibitors in people with HIV in the USA and Canada: a cohort study. Lancet HIV. 2026 May; 13(5):e297-e305.
Score: 0.238
-
Changes in weight and glycemia after initiation of integrase strand transfer inhibitors among people with HIV and diabetes. AIDS. 2026 Aug 01; 40(8):1180-1189.
Score: 0.238
-
Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada. J Int AIDS Soc. 2020 04; 23(4):e25484.
Score: 0.157